WallStreetZenWallStreetZen

NASDAQ: LIVN
Livanova PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for LIVN

Based on 4 analysts offering 12 month price targets for Livanova PLC

Min Forecast
$58.00-9.23%
Avg Forecast
$65.50+2.5%
Max Forecast
$70.00+9.55%

Should I buy or sell LIVN stock?

Based on 4 analysts offering ratings for Livanova PLC.

Buy
Strong Buy
0 analysts 0%
Buy
3 analysts 75%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their LIVN stock forecasts and price targets.

LIVN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-13
lockedlocked$00.00+00.00%2025-11-13
lockedlocked$00.00+00.00%2025-09-03
lockedlocked$00.00+00.00%2025-08-21

1 of 1

Forecast return on equity

Is LIVN forecast to generate an efficient return?

Company
24.47%
Industry
28.48%
Market
228.88%
LIVN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LIVN forecast to generate an efficient return on assets?

Company
11.07%
Industry
13.33%
LIVN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LIVN earnings per share forecast

What is LIVN's earnings per share in the next 3 years based on estimates from 13 analysts?

Avg 1 year Forecast
$3.93
Avg 2 year Forecast
$4.22
Avg 3 year Forecast
$4.55

LIVN revenue forecast

What is LIVN's revenue in the next 3 years based on estimates from 13 analysts?

Avg 1 year Forecast
$1.4B+4.3%
Avg 2 year Forecast
$1.5B+11.34%
Avg 3 year Forecast
$1.6B+18.46%
LIVN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LIVN revenue growth forecast

How is LIVN forecast to perform vs Medical Devices companies and vs the US market?

Company
5.81%
Industry
7.14%
Market
25.69%
LIVN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LIVN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LIVN vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
LIVN$63.90$65.50+2.50%Buy
ATEC$21.28$21.70+1.97%Strong Buy
INSP$140.03$125.71-10.22%Buy
ITGR$70.62$84.17+19.18%Buy
TMDX$138.63$141.88+2.34%Buy
View Top Medical Device Stocks

Livanova Stock Forecast FAQ

Is Livanova Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: LIVN) stock is to Buy LIVN stock.

Out of 4 analysts, 0 (0%) are recommending LIVN as a Strong Buy, 3 (75%) are recommending LIVN as a Buy, 1 (25%) are recommending LIVN as a Hold, 0 (0%) are recommending LIVN as a Sell, and 0 (0%) are recommending LIVN as a Strong Sell.

If you're new to stock investing, here's how to buy Livanova stock.

What is LIVN's earnings growth forecast for 2025-2027?

(NASDAQ: LIVN) Livanova's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 14.34%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.81%.

Livanova's earnings in 2025 is -$217,486,000.On average, 13 Wall Street analysts forecast LIVN's earnings for 2025 to be $214,823,604, with the lowest LIVN earnings forecast at $204,421,251, and the highest LIVN earnings forecast at $223,036,275. On average, 13 Wall Street analysts forecast LIVN's earnings for 2026 to be $230,418,942, with the lowest LIVN earnings forecast at $216,194,202, and the highest LIVN earnings forecast at $243,677,164.

In 2027, LIVN is forecast to generate $248,580,741 in earnings, with the lowest earnings forecast at $222,615,812 and the highest earnings forecast at $271,198,350.

What is LIVN's revenue growth forecast for 2025-2027?

(NASDAQ: LIVN) Livanova's forecast annual revenue growth rate of 5.81% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.69%.

Livanova's revenue in 2025 is $1,348,962,000.On average, 13 Wall Street analysts forecast LIVN's revenue for 2025 to be $76,829,976,489, with the lowest LIVN revenue forecast at $73,226,011,707, and the highest LIVN revenue forecast at $79,396,436,258. On average, 13 Wall Street analysts forecast LIVN's revenue for 2026 to be $82,017,501,554, with the lowest LIVN revenue forecast at $77,266,820,705, and the highest LIVN revenue forecast at $85,949,099,498.

In 2027, LIVN is forecast to generate $87,259,632,146 in revenue, with the lowest revenue forecast at $81,143,813,122 and the highest revenue forecast at $91,791,890,887.

What is LIVN's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: LIVN) forecast ROA is 11.07%, which is lower than the forecast US Medical Devices industry average of 13.33%.

What is LIVN's Price Target?

According to 4 Wall Street analysts that have issued a 1 year LIVN price target, the average LIVN price target is $65.50, with the highest LIVN stock price forecast at $70.00 and the lowest LIVN stock price forecast at $58.00.

On average, Wall Street analysts predict that Livanova's share price could reach $65.50 by Nov 13, 2026. The average Livanova stock price prediction forecasts a potential upside of 2.5% from the current LIVN share price of $63.90.

What is LIVN's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: LIVN) Livanova's current Earnings Per Share (EPS) is -$3.99. On average, analysts forecast that LIVN's EPS will be $3.93 for 2025, with the lowest EPS forecast at $3.74, and the highest EPS forecast at $4.08. On average, analysts forecast that LIVN's EPS will be $4.22 for 2026, with the lowest EPS forecast at $3.96, and the highest EPS forecast at $4.46. In 2027, LIVN's EPS is forecast to hit $4.55 (min: $4.08, max: $4.97).

What is LIVN's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: LIVN) forecast ROE is 24.47%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.